These results strongly suggest that the expansion of Treg cells in colorectal cancer patients was nurtured by the generation of new Treg cells in the thymus and the further increase of Treg-cell frequencies post IL-2 administration was strongly associated with an increase of thymic emigrants of naïve Treg cells. The gene discussed is IL2; the disease is colorectal cancer.